Advasa Holdings, Inc. filed a Form 8-K on October 27, 2026, disclosing that it received a written notice from Nasdaq on October 21, 2026, indicating its common stock had failed to meet the $1.00 minimum bid price requirement for continued listing on the Nasdaq Global Market.

Key Highlights

  • Deficiency notice received: Advasa Holdings received written notice from Nasdaq on October 21, 2026, citing failure to maintain the $1.00 minimum bid price for the prior 30 consecutive business days.
  • Listing rule cited: The notice references Nasdaq Listing Rule 5450(a)(1), the Minimum Bid Price Requirement for the Nasdaq Global Market.
  • 180-day compliance window: The company has until April 19, 2027, to regain compliance with the minimum bid price requirement.
  • Compliance path: Nasdaq staff will notify the company if its stock meets the applicable standard for at least ten consecutive business days before the deadline.
  • Transfer option available: If compliance is not regained by April 19, 2027, the company may be eligible to transfer to the Nasdaq Capital Market, subject to meeting applicable requirements.
  • No immediate trading impact: According to the filing, the notice "has no immediate effect on the listing or trading of the Company's common stock," which continues to trade under the symbol "ADBT" on the Nasdaq Global Market.

Advasa Holdings Discloses Nasdaq Minimum Bid Price Deficiency and Compliance Timeline

According to the Form 8-K filed with the SEC, Advasa Holdings, Inc. (NASDAQ:ADBT) received written notice from The Nasdaq Stock Market LLC on October 21, 2026, stating that the company's common stock had traded below the $1.00 per share minimum bid price for the last 30 consecutive business days. This failure implicates Nasdaq Listing Rule 5450(a)(1), which governs continued listing on the Nasdaq Global Market.

The filing states that under Nasdaq Listing Rule 5810(c)(3)(A), the company has been granted an initial compliance period of 180 calendar days, running until April 19, 2027. During this period, if the closing bid price of the company's common stock meets or exceeds $1.00 per share for a minimum of ten consecutive business days at any point before the deadline, Nasdaq staff will issue written notification confirming the company has achieved compliance. The company disclosed that it "intends to actively monitor the closing bid price of its common stock and may, if appropriate, consider available options to regain compliance."

Should Advasa Holdings fail to regain compliance by April 19, 2027, the filing describes an alternative route: the company could transfer its listing to the Nasdaq Capital Market, provided it meets the applicable market value of publicly held shares and all other initial listing requirements except the bid price requirement, and notifies Nasdaq of its intent to cure the deficiency. If neither compliance nor a qualifying transfer is achieved, Nasdaq staff would issue a delisting notice, which the company could appeal to a Nasdaq hearings panel. The filing notes that "there can be no assurance" that the company will regain compliance, secure an extension, or meet transfer requirements. The filing was signed by Chief Executive Officer Grady Ryther.

What Was Disclosed

Advasa Holdings reported receiving a Nasdaq deficiency notice on October 21, 2026, for failing the $1.00 minimum bid price rule over 30 consecutive business days. The company has until April 19, 2027, to regain compliance, with no immediate effect on trading under "ADBT."